4-[2-(5-Chloro-2-oxo-2,3-dihydro-1,3-benzothiazol-3-yl)-acetamido]benzoic Acid

ID: ALA3590512

Chembl Id: CHEMBL3590512

PubChem CID: 122181671

Max Phase: Preclinical

Molecular Formula: C16H11ClN2O4S

Molecular Weight: 362.79

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(Cn1c(=O)sc2ccc(Cl)cc21)Nc1ccc(C(=O)O)cc1

Standard InChI:  InChI=1S/C16H11ClN2O4S/c17-10-3-6-13-12(7-10)19(16(23)24-13)8-14(20)18-11-4-1-9(2-5-11)15(21)22/h1-7H,8H2,(H,18,20)(H,21,22)

Standard InChI Key:  RHHHPTFTBKCDFL-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3590512

    ---

Associated Targets(Human)

TRAF6 Tbio TNF receptor-associated factor 6 (20 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 362.79Molecular Weight (Monoisotopic): 362.0128AlogP: 3.05#Rotatable Bonds: 4
Polar Surface Area: 88.40Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 4.16CX Basic pKa: CX LogP: 3.03CX LogD: -0.03
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.75Np Likeness Score: -1.98

References

1. Moriya J, Takeuchi K, Tai K, Arai K, Kobayashi N, Yoneda N, Fukunishi Y, Inoue A, Kihara M, Murakami T, Chiba K, Shimada I..  (2015)  Structure-Based Development of a Protein-Protein Interaction Inhibitor Targeting Tumor Necrosis Factor Receptor-Associated Factor 6.,  58  (14): [PMID:26132273] [10.1021/acs.jmedchem.5b00778]

Source